Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort studyCOVID-19를 가진 중환자 환자에서 토 실리 주맙과 떠오르는 다제 내성 유기체 사이의 연관성 : 다기관, 후 향적 코호트 연구Multicenter Study Published on 2021-11-012022-09-01 Journal: BMC Infectious Diseases [Category] [DOI] 10.1186/s12879-021-06813-1 PMC 바로가기 [Article Type] Multicenter Study
Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2SARS-CoV-2에 감염된 중환자를 위한 치료제로서의 토실리주맙Multicenter Study Published on 2021-11-012022-09-12 Journal: Clinical and translational science [Category] [DOI] 10.1111/cts.12894 PMC 바로가기 [Article Type] Multicenter Study
The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study기계적 환기가 필요하지 않은 중증 COVID-19 환자에 대한 레빌리맙의 효능 및 안전성: 다기관 무작위 이중맹검 위약 대조 3상 CORONA 임상 연구 결과Clinical Trial Published on 2021-09-292022-09-12 Journal: Inflammation research : official journal of the Eu [Category] [DOI] 10.1007/s00011-021-01507-5 PMC 바로가기 [Article Type] Clinical Trial
Tocilizumab in COVID-19: The Cerrahpaşa-PREDICT scoreCOVID-19의 Tocilizumab: Cerrahpaşa-PREDICT 점수Article Published on 2021-09-012022-09-12 Journal: Journal of infection and chemotherapy : official j [Category] [DOI] 10.1016/j.jiac.2021.05.007 PMC 바로가기 [Article Type] Article
Risk of Reactivation of Hepatitis B Virus (HBV) and Tuberculosis (TB) and Complications of Hepatitis C Virus (HCV) Following Tocilizumab Therapy: A Systematic Review to Inform Risk Assessment in the COVID-19 EraMedicine Published on 2021-08-202022-10-31 Journal: Frontiers in Medicine [Category] [DOI] 10.3389/fmed.2021.706482 PMC 바로가기 [Article Type] Medicine
Epidemiology and Clinical Management of Rheumatic Autoimmune Diseases in the COVID-19 Pandemic: A ReviewMedicine Published on 2021-08-192022-10-31 Journal: Frontiers in Medicine [Category] [DOI] 10.3389/fmed.2021.725226 PMC 바로가기 [Article Type] Medicine
Donor genetic variants in interleukin-6 and interleukin-6 receptor associate with biopsy-proven rejection following kidney transplantationArticle Published on 2021-08-132022-10-04 Journal: Scientific Reports [Category] [DOI] 10.1038/s41598-021-95714-z PMC 바로가기 [Article Type] Article
Safety of tocilizumab in COVID-19 pregnant women and their newborn: A retrospective studyCOVID-19 임산부와 신생아에서 토실리주맙의 안전성: 후향적 연구Multicenter Study Published on 2021-08-012022-09-11 Journal: Journal of clinical pharmacy and therapeutics [Category] [DOI] 10.1111/jcpt.13394 PMC 바로가기 [Article Type] Multicenter Study
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first updateCOVID-19 환자에서 토실리주맙의 효능 및 안전성: 살아있는 체계적인 검토 및 메타 분석, 첫 번째 업데이트Meta-Analysis Published on 2021-08-012022-09-12 Journal: Clinical microbiology and infection : the official [Category] [DOI] 10.1016/j.cmi.2021.04.019 PMC 바로가기 [Article Type] Meta-Analysis
Editorial: Tocilizumab, a Humanized Therapeutic IL-6 Receptor (IL-6R) Monoclonal Antibody, and Future Combination Therapies for Severe COVID-19사설: Tocilizumab, 인간화 치료 IL-6 수용체(IL-6R) 단클론항체 및 중증 COVID-19에 대한 미래 조합 요법Editorial Published on 2021-07-192022-09-12 Journal: Medical science monitor : international medical jo [Category] [DOI] 10.12659/MSM.933973 PMC 바로가기 [Article Type] Editorial